NCT03085914 A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) Status COMPLETED Phase PHASE1/PHASE2
NCT03080311 A Study of APG-1252 in Patients With SCLC or Other Solid Tumors Status COMPLETED Phase PHASE1
NCT03057145 Combination Study of Prexasertib and Olaparib in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03053466 APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors Status COMPLETED Phase PHASE1
NCT03051477 Trial of Mistletoe Extract in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03042910 A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03027284 A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT03027128 QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03015324 Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors Status COMPLETED Phase PHASE1
NCT03013491 PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas Status TERMINATED Phase PHASE1/PHASE2
NCT03013218 A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) Status COMPLETED Phase PHASE1
NCT03009292 Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor Status COMPLETED Phase PHASE1
NCT03006172 To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02986100 Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib Status COMPLETED Phase PHASE1
NCT02974738 A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02968485 Phase I Study of SHR7390 in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1